Myocardial fibrosis in congenital heart disease
Date
2022-11-18Permanent link
https://hdl.handle.net/11351/8728DOI
10.3389/fped.2022.965204
ISSN
2296-2360
PMID
36467466
Abstract
Myocardial fibrosis resulting from the excessive deposition of collagen fibers through the myocardium is a common histopathologic finding in a wide range of cardiovascular diseases, including congenital anomalies. Interstitial fibrosis has been identified as a major cause of myocardial dysfunction since it distorts the normal architecture of the myocardium and impairs the biological function and properties of the interstitium. This review summarizes current knowledge on the mechanisms and detrimental consequences of myocardial fibrosis in heart failure and arrhythmias, discusses the usefulness of available imaging techniques and circulating biomarkers to assess this entity and reviews the current body of evidence regarding myocardial fibrosis in the different subsets of congenital heart diseases with implications in research and treatment.
Keywords
Collagen biomarkers; Congenital heart disease; Myocardial fibrosisBibliographic citation
Gordon B, González-Fernández V, Dos-Subirà L. Myocardial fibrosis in congenital heart disease. Front Pediatr. 2022 Nov 18;10:965204.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
The following license files are associated with this item:





